CN111729040A - 一种具有改善睡眠作用的袋泡茶及其制备方法 - Google Patents
一种具有改善睡眠作用的袋泡茶及其制备方法 Download PDFInfo
- Publication number
- CN111729040A CN111729040A CN202010662981.1A CN202010662981A CN111729040A CN 111729040 A CN111729040 A CN 111729040A CN 202010662981 A CN202010662981 A CN 202010662981A CN 111729040 A CN111729040 A CN 111729040A
- Authority
- CN
- China
- Prior art keywords
- parts
- teabag
- sleep
- improving effect
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 241000208340 Araliaceae Species 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 15
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 15
- 235000007215 black sesame Nutrition 0.000 claims abstract description 15
- 235000008113 selfheal Nutrition 0.000 claims abstract description 15
- 241000005787 Cistanche Species 0.000 claims abstract description 14
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract 5
- 210000000582 semen Anatomy 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 238000007873 sieving Methods 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 8
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000002490 cerebral effect Effects 0.000 abstract description 4
- 230000003860 sleep quality Effects 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 5
- 241001122767 Theaceae Species 0.000 description 15
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 13
- 206010022437 insomnia Diseases 0.000 description 13
- 240000003582 Platycodon grandiflorus Species 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000006386 memory function Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229930192286 jujuboside Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明实施例公开了一种具有改善睡眠作用的袋泡茶及其制备方法,属于袋泡茶技术领域。一种具有改善睡眠作用的袋泡茶,包括如下重量份原料:人参1‑3份、桔梗5‑10份、黑芝麻5‑10份、灸黄精5‑10份、肉苁蓉5‑10份、淡竹叶5‑10份、炒酸枣仁5‑10份、夏枯草5‑10份。本发明实施例的袋泡茶以人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草为原料,各组分之间协同增效,能够显著改善患者的睡眠质量,同时还具有提升免疫力,调理脑供血不足的功效。本发明采用的原材料属于药食同源的原料,具有安全无毒的特点,适合长期服用,具有广泛推广应用价值。
Description
技术领域
本发明实施例涉及袋泡茶技术领域,具体涉及一种具有改善睡眠作用的袋泡茶及其制备方法。
背景技术
由于现代社会生活节奏快、工作压力大,患有失眠症状的人群越来越年轻化,表现为不易入眠,或睡眠短浅易醒,甚至整夜不能入眠。另外,随着人口老龄化,越来越多人出现脑供血不足,常伴有心烦、耳鸣、烦躁易怒、失眠多梦等症状。失眠严重影响着人类的生活质量。西医常用镇定安神药物治疗失眠,虽然可以缓解症状,但长时间服用则会带来一定的副作用,且停药后复发率较高。
在《内经》中将失眠称为“目不瞑”、“不得眠、“不得卧”,为各种原因导致神不守舍所引起的睡眠障碍性疾病。中医以辩证治疗,副作用小等特点,成为现代治疗失眠的首选方法之一。
现有用于治疗失眠的中药配伍性不强,存在疗效不显著的缺陷。因此,需求研发出一种疗效显著、安全无副作用的改善睡眠作用的中药组合物。
发明内容
为此,本发明实施例提供一种具有改善睡眠作用的袋泡茶及其制备方法,该组合物协同性好,疗效显著且安全无副作用,以解决现有技术中存在的问题。
为了实现上述目的,本发明实施例提供如下技术方案:
根据本发明实施例的第一方面,本发明实施例提供一种具有改善睡眠作用的袋泡茶,包括如下重量份原料:
人参1-3份、桔梗5-10份、黑芝麻5-10份、灸黄精5-10份、肉苁蓉5-10份、淡竹叶5-10份、炒酸枣仁5-10份、夏枯草5-10份。
在一个优选的实施例中,包括如下重量份原料:
人参1-3份、桔梗8-10份、黑芝麻6-8份、灸黄精8-10份、肉苁蓉8-10份、淡竹叶5-8份、炒酸枣仁6-8份、夏枯草5-7份。
在一个优选的实施例中,包括如下重量份原料:
人参2份、桔梗10份、黑芝麻8份、灸黄精8份、肉苁蓉10份、淡竹叶6份、炒酸枣仁7份、夏枯草5份。
其中:人参:味甘、微苦,性平。归脾、肺、心经。功能主治大补元气,复脉固脱,补脾益肺,生津,安神。用于体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。
桔梗:味苦、辛,性平。归肺经。功能主治宣肺,利咽,祛痰,排脓。用于咳嗽痰多,胸闷不畅,咽痛,音哑,肺痈吐脓,疮疡脓成不溃。
黑芝麻:性平,味甘。归肝经、肾经、大肠经。功能主治补肝肾、益精血、润肠燥。用治头晕眼花、耳鸣耳聋、须发早白、病后脱发、肠燥便秘、肝肾不足、风痹、瘫痪、妇人乳少。
灸黄精:炙黄精具有抗菌消炎,滋阴润肺的功效。可用于治疗口干,口渴,口臭,心悸,胸闷,气短,失眠,多梦,记忆力减退,四肢无力,腰酸背痛,足癣,湿疹,手癣,荨麻疹。它含有黄精多糖,天冬多氨酸,高丝氨酸,抑制体内黑色素的沉淀,抗氧化,清除自由基,抗衰老,增强人体的免疫力,调节内分泌功能,抑制金黄色葡萄球菌,大肠杆菌,伤寒杆菌的作用。
肉苁蓉:味甘;咸;性温。归肾;大肠经。补肾阳;益精血;润肠道。
淡竹叶:甘、淡,寒。归心、胃、小肠经。功能主治清热除烦,利尿。用于热病烦渴,小便赤涩淋痛,口舌生疮。
炒酸枣仁:酸枣仁中含有的酸枣仁总甙能够降低血清胆固醇,升高高密度脂蛋白。具有调节人体的血压和血脂、镇静和催眠、保护心血管系统的作用。
夏枯草:味辛、苦,性寒。归肝、胆经。功效清肝泻火,明目,散结消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,乳痈,乳癖,乳房胀痛。
根据本发明实施例的第二方面,本发明实施例提供一种上述的具有改善睡眠作用的袋泡茶的制备方法,所述方法包括:
将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草烘干后,分别粉碎,过筛,按重量比例进行配料,充分搅拌,混合均匀,装袋,紫外线杀菌,包装。
在一个优选的实施例中,所述烘干步骤中,烘干温度为50-70℃。
在一个优选的实施例中,所述过筛步骤中,过100-200目筛。
在一个优选的实施例中,所述装袋步骤中,装入量为10-15g。
在一个优选的实施例中,所述紫外线杀菌步骤中,紫外线照射6-8小时。
本发明实施例具有如下优点:
本发明实施例的袋泡茶以人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草为原料,各组分之间协同增效,能够显著改善患者的睡眠质量,同时还具有提升免疫力,调理脑供血不足的功效。本发明采用的原材料属于药食同源的原料,具有安全无毒的特点,适合长期服用,具有广泛推广应用价值。
具体实施方式
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。以下实施例中无特殊说明情况下,“份”均指重量份数。
实施例1
本实施例的一种具有改善睡眠作用的袋泡茶的制备方法包括以下步骤:
1)将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草在60℃烘干后,分别粉碎,过150目筛;
2)按人参1份、桔梗8份、黑芝麻6份、灸黄精5份、肉苁蓉10份、淡竹叶8份、炒酸枣仁6份、夏枯草5份进行配料,充分搅拌,混合均匀,装袋,紫外线照射8小时,包装。
实施例2
本实施例的一种具有改善睡眠作用的袋泡茶的制备方法包括以下步骤:
1)将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草在50℃烘干后,分别粉碎,过150目筛;
2)按人参2份、桔梗10份、黑芝麻8份、灸黄精8份、肉苁蓉10份、淡竹叶6份、炒酸枣仁7份、夏枯草5份进行配料,充分搅拌,混合均匀,装袋,紫外线照射6小时,包装。
实施例3
本实施例的一种具有改善睡眠作用的袋泡茶的制备方法包括以下步骤:
1)将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草在50℃烘干后,分别粉碎,过200目筛;
2)按人参2份、桔梗5份、黑芝麻7份、灸黄精9份、肉苁蓉7份、淡竹叶5份、炒酸枣仁6份、夏枯草8份进行配料,充分搅拌,混合均匀,装袋,紫外线照射8小时,包装。
实施例4
本实施例的一种具有改善睡眠作用的袋泡茶的制备方法包括以下步骤:
1)将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草在70℃烘干后,分别粉碎,过100目筛;
2)按人参3份、桔梗5份、黑芝麻10份、灸黄精5份、肉苁蓉7份、淡竹叶9份、炒酸枣仁10份、夏枯草5份进行配料,充分搅拌,混合均匀,装袋,紫外线照射8小时,包装。
实施例5
本实施例的一种具有改善睡眠作用的袋泡茶的制备方法包括以下步骤:
1)将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草在60℃烘干后,分别粉碎,过100目筛;
2)按人参2份、桔梗10份、黑芝麻5份、灸黄精5份、肉苁蓉5份、淡竹叶9份、炒酸枣仁5份、夏枯草10份进行配料,充分搅拌,混合均匀,装袋,紫外线照射8小时,包装。
测试例
为了说明本发明实施例的袋泡茶具有改善睡眠作用,进行了以下临床试验。
选择240例自愿接受本次试验的具有失眠症状的患者,女118例,男122例,年龄20-70岁,平均年龄48.5岁。其中,因压力大而导致的失眠患者104名,症状:入睡困难、睡眠质量下降和睡眠时间减少,记忆功能下降,免疫力下降。因患有脑供血不足而导致失眠患者136例,症状:胸闷、心悸、血压不稳定。将所有患者随机分为试验组和对照组,每组各120人,两组患者的一般资料无统计学差异,具有可比性。
研究方法:试验组患者使用实施例3的袋泡茶(重15g),使用方法:将袋泡茶置于200mL以上的杯中,冲满开水,加盖,半小时后饮用,饮完后用开水反复冲泡数次续服,直至药味变淡,每天1剂。对照组患者口服艾司唑仑片,1-2mg/次,每晚睡前服用。试验组和对照组连续治疗1个月。
疗效标准:显效:睡眠情况得到很好的改善,记忆功能提高,免疫力增强,患者胸闷、心悸、血压不稳定症状消失;有效:睡眠情况有所改善,记忆功能有所提高,胸闷、心悸、血压不稳定症状有所缓解;无效:睡眠情况无改善,病症无变化。
两组患者治疗情况比较结果见表1。
表1
组别 | 显效 | 有效 | 无效 | 有效率 |
试验组 | 48 | 62 | 10 | 91.67% |
对照组 | 28 | 49 | 43 | 64.17% |
由表1可知,与对照组相比较,试验组患者在使用本发明实施例的袋泡茶后,睡眠情况得到了有效的改善,改善情况明显优于对照组,且差异有统计学意义(P<0.05)。
试验组患者在使用本发明实施例的袋泡茶后,身体未出现明显的改变,且未发生过敏及其他不良反应,说明本发明实施例的袋泡茶安全无毒副作用,可长期饮用。
虽然,上文中已经用一般性说明及具体实施例对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (8)
1.一种具有改善睡眠作用的袋泡茶,其特征在于,包括如下重量份原料:
人参1-3份、桔梗5-10份、黑芝麻5-10份、灸黄精5-10份、肉苁蓉5-10份、淡竹叶5-10份、炒酸枣仁5-10份、夏枯草5-10份。
2.根据权利要求1所述的具有改善睡眠作用的袋泡茶,其特征在于,包括如下重量份原料:
人参1-3份、桔梗8-10份、黑芝麻6-8份、灸黄精8-10份、肉苁蓉8-10份、淡竹叶5-8份、炒酸枣仁6-8份、夏枯草5-7份。
3.根据权利要求1所述的具有改善睡眠作用的袋泡茶,其特征在于,包括如下重量份原料:
人参2份、桔梗10份、黑芝麻8份、灸黄精8份、肉苁蓉10份、淡竹叶6份、炒酸枣仁7份、夏枯草5份。
4.一种权利要求1-3任一所述的具有改善睡眠作用的袋泡茶的制备方法,其特征在于,所述方法包括:
将人参、桔梗、黑芝麻、灸黄精、肉苁蓉、淡竹叶、炒酸枣仁、夏枯草烘干后,分别粉碎,过筛,按重量比例进行配料,充分搅拌,混合均匀,装袋,紫外线杀菌,包装。
5.根据权利要求4所述的具有改善睡眠作用的袋泡茶的制备方法,其特征在于,所述烘干步骤中,烘干温度为50-70℃。
6.根据权利要求4所述的具有改善睡眠作用的袋泡茶的制备方法,其特征在于,所述过筛步骤中,过100-200目筛。
7.根据权利要求4所述的具有改善睡眠作用的袋泡茶的制备方法,其特征在于,所述装袋步骤中,装入量为10-15g。
8.根据权利要求4所述的具有改善睡眠作用的袋泡茶的制备方法,其特征在于,所述紫外线杀菌步骤中,紫外线照射6-8小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010662981.1A CN111729040A (zh) | 2020-07-10 | 2020-07-10 | 一种具有改善睡眠作用的袋泡茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010662981.1A CN111729040A (zh) | 2020-07-10 | 2020-07-10 | 一种具有改善睡眠作用的袋泡茶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111729040A true CN111729040A (zh) | 2020-10-02 |
Family
ID=72654214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010662981.1A Pending CN111729040A (zh) | 2020-07-10 | 2020-07-10 | 一种具有改善睡眠作用的袋泡茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111729040A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198178A (zh) * | 2011-05-24 | 2011-09-28 | 北京京蒙五鑫科技开发有限公司 | 珍蓉益脑胶囊 |
CN110638945A (zh) * | 2019-09-26 | 2020-01-03 | 宁波德康生物制品有限公司 | 一种安神助眠的代用茶及其制备方法 |
-
2020
- 2020-07-10 CN CN202010662981.1A patent/CN111729040A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198178A (zh) * | 2011-05-24 | 2011-09-28 | 北京京蒙五鑫科技开发有限公司 | 珍蓉益脑胶囊 |
CN110638945A (zh) * | 2019-09-26 | 2020-01-03 | 宁波德康生物制品有限公司 | 一种安神助眠的代用茶及其制备方法 |
Non-Patent Citations (2)
Title |
---|
王佳宁: "基于临床证据的中药复方口服治疗失眠症的组方用药规律研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
陈秀杉: "黄精为镇静良药", 《中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104258045B (zh) | 一种润肠通便的中药及其制备方法 | |
CN105233119A (zh) | 一种增强中老年人机体免疫力的中药组合物及其制备方法 | |
CN112022957A (zh) | 一种中药润肺排毒清肺茶 | |
CN110613134B (zh) | 具有降血糖功能的保健食品及其制备方法 | |
CN111494487A (zh) | 一种有助愉悦心情的中药组合物及其外用制剂和应用 | |
US10953062B2 (en) | Anticancer pharmaceutical composition and application thereof | |
CN110637962A (zh) | 一种滋阴温阳补肾的药食两用植物固体饮料 | |
CN111729040A (zh) | 一种具有改善睡眠作用的袋泡茶及其制备方法 | |
CN103446283B (zh) | 一种防治化疗性口腔炎的药物组合物 | |
CN106822536B (zh) | 一种治疗猪弓形虫病的中药组合物及其制备方法与应用 | |
CN115399476A (zh) | 一种具有辅助润肠通便功能的食品组合物 | |
CN105639517A (zh) | 枇杷膏及其制备方法 | |
CN112772812A (zh) | 一种益气润肠通便的组合物及其制备方法 | |
CN101406625B (zh) | 一种治疗癌症的中药组合物及其制备方法和用途 | |
CN112641911A (zh) | 一种快速治疗遗尿与早泄的药物 | |
CN107519473A (zh) | 一种润肺止咳组合物及其制备方法 | |
CN103550351B (zh) | 治疗偏头疼的中药组合物及其制备方法 | |
CN102793031A (zh) | 枇杷润喉茶及其制备方法 | |
CN112843151A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN105687985A (zh) | 一种补骨脂暖脾止泻口服液及其生产方法 | |
CN106511839A (zh) | 美容养颜祛斑调经的中药组合物及使用方法 | |
CN105796962A (zh) | 一种安神的药物组合物及其制备方法 | |
CN114515332A (zh) | 一种养发生发植物组合物及其制备方法 | |
CN111567795A (zh) | 一种可以使男性阴茎增大的膳食补充剂及制备方法 | |
CN105853480A (zh) | 元宝枫在制备具有改善睡眠功能的保健食品或药品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201002 |